Middle East Journal of Rehabilitation and Health

Published by: Kowsar

Effects of Alpha Lipoic Acid Treatment on Laminin Alteration of the Sciatic Nerve in Streptozotocin Induced Diabetic Rats

Mohammad Reza Aldaghi 1 , * , Mojtaba Sankian 2 , Hamid Reza Sameni 1 and Manouchehr Safari 1
Authors Information
1 Department of Anatomy, School of Medicine, Semnan University of Medical Sciences, Semnan, IR Iran
2 Immunology Research Center, Bu-Ali Research Institute, Medical School, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Middle East Journal of Rehabilitation and Health: October 01, 2014, 1 (2); e23471
  • Published Online: September 16, 2014
  • Article Type: Research Article
  • Received: February 19, 2014
  • Revised: February 26, 2014
  • Accepted: March 5, 2014
  • DOI: 10.17795/mejrh-23471

To Cite: Aldaghi M R, Sankian M, Sameni H R, Safari M. Effects of Alpha Lipoic Acid Treatment on Laminin Alteration of the Sciatic Nerve in Streptozotocin Induced Diabetic Rats, Middle East J Rehabil Health Stud. 2014 ; 1(2):e23471. doi: 10.17795/mejrh-23471.

Copyright © 2014, Semnan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Bahcelioglu M, Elmas C, Kurkcuoglu A, Calguner E, Erdogan D, Kadioglu D, et al. Age-related immunohistochemical and ultrastructural changes in rat oculomotor nerve. Anat Histol Embryol. 2008; 37(4): 279-84[DOI][PubMed]
  • 2. Bradley JL, King RH, Muddle JR, Thomas PK. The extracellular matrix of peripheral nerve in diabetic polyneuropathy. Acta Neuropathol. 2000; 99(5): 539-46[PubMed]
  • 3. Layton BE, Sastry AM, Wang H, Sullivan KA, Feldman EL, Komorowski TE, et al. Differences between collagen morphologies, properties and distribution in diabetic and normal biobreeding and Sprague-Dawley rat sciatic nerves. J Biomech. 2004; 37(6): 879-88[DOI][PubMed]
  • 4. Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, et al. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol. 1995; 5(8): 1610-7[PubMed]
  • 5. Podratz JL, Rodriguez E, Windebank AJ. Role of the extracellular matrix in myelination of peripheral nerve. Glia. 2001; 35(1): 35-40[PubMed]
  • 6. Hill R. Extracellular matrix remodelling in human diabetic neuropathy. J Anat. 2009; 214(2): 219-25[DOI][PubMed]
  • 7. Hohenester E, Yurchenco PD. Laminins in basement membrane assembly. Cell Adh Migr. 2013; 7(1): 56-63
  • 8. Yasuda H, Terada M, Maeda K, Kogawa S, Sanada M, Haneda M, et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol. 2003; 69(4): 229-85[PubMed]
  • 9. Duran-Jimenez B, Dobler D, Moffatt S, Rabbani N, Streuli CH, Thornalley PJ, et al. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes. 2009; 58(12): 2893-903[DOI][PubMed]
  • 10. Han T, Bai J, Liu W, Hu Y. A systematic review and meta-analysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol. 2012; 167(4): 465-71[DOI][PubMed]
  • 11. Vallianou N, Evangelopoulos A, Koutalas P. Alpha-lipoic Acid and diabetic neuropathy. Rev Diabet Stud. 2009; 6(4): 230-6[DOI][PubMed]
  • 12. Rajbhandari SM, Piya MK. A brief review on the pathogenesis of human diabetic neuropathy: observations and postulations. Int J Diabetes Metab. 2005; 13(3): 135-40
  • 13. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol. 2004; 3(3): 173-89[PubMed]
  • 14. Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int. 2005; 67(4): 1371-80[DOI][PubMed]
  • 15. Ranieri M, Sciuscio M, Cortese A, Stasi M, Panza F, Megna M, et al. Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries. J Brachial Plex Peripher Nerve Inj. 2010; 5: 15[DOI][PubMed]
  • 16. Melhem MF, Craven PA, Liachenko J, DeRubertis FR. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol. 2002; 13(1): 108-16[PubMed]
  • 17. Ishiyama A, Mowry SE, Lopez IA, Ishiyama G. Immunohistochemical distribution of basement membrane proteins in the human inner ear from older subjects. Hear Res. 2009; 254(1-2): 1-14[DOI][PubMed]
  • 18. Kranenburg AR, Willems-Widyastuti A, Moori WJ, Sterk PJ, Alagappan VK, de Boer WI, et al. Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease. Am J Clin Pathol. 2006; 126(5): 725-35[PubMed]
  • 19. Head KA. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev. 2006; 11(4): 294-329
  • 20. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes. 2000; 49(6): 1006-15[PubMed]
  • 21. Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des. 2008; 14(10): 953-61[PubMed]
  • 22. Burekovic A, Terzic M, Alajbegovic S, Vukojevic Z, Hadzic N. The role of alpha-lipoic acid in diabetic polyneuropathy treatment. Bosn J Basic Med Sci. 2008; 8(4): 341-5[PubMed]
  • 23. Sotnikova R, Skalska S, Okruhlicova L, Navarova J, Kyselova Z, Zurova J, et al. Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocin-induced diabetes. Gen Physiol Biophys. 2006; 25(3): 289-302[PubMed]
  • 24. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes. 1992; 41(12): 1520-7[PubMed]
  • 25. Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes. 2002; 51(9): 2826-32[PubMed]
  • 26. Serafín A, Molín J, Márquez M, Blasco E, Vidal E, Foradada L, et al. Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFN beta in beta cells. Muscle Nerve J. 2010; 41(5): 630-641
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments